Drug Database
Back to search

Belgium· BE-AMP-SAM427655-00

Lidorat 20 mg - 5 mg

A atorvastatin and amlodipine product containing atorvastatin lysine, registered in Belgium by Medimpex France. The same ATC class is registered in 7 of our 19 countries.

ATC C10BX03

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedLidorat 20 mg - 5 mgATCC10BX03REGISTER NO.BE-AMP-SAM427655-00PACKS LISTED0CHECKEDSeptember 26, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about atorvastatin lysineAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Atorvastatin and amlodipine is registered in 7 of 19 countries.

Countries holding a registration under ATC C10BX03 (atorvastatin and amlodipine), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 6 of them publish a price we can compare per daily dose
Search atorvastatin and amlodipine products by name

Atorvastatin and amlodipine · ATC C10BX03

7 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Finlandprice
  • Polandprice
  • Switzerlandprice
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Atorvastatin Lysine
Manufacturer
Medimpex France
Country
Belgium (BE)
ATC code
C10BX03
ATC class
Atorvastatin and amlodipine
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

4 interactions on record for atorvastatin and amlodipine.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check atorvastatin and amlodipine against other medicinesHow interaction checks work

Atorvastatin and amlodipine · interactions on record

4 records

4 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Same class

Other records under C10BX03

Atorvastatin and amlodipine, as other registers publish it.

All atorvastatin and amlodipine products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c9eeaffc-da8f-4de5-b67c-49ff6b48d55c
GET /v1/drugs/c9eeaffc-da8f-4de5-b67c-49ff6b48d55c?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Film-coated tablet",
  "source": "afmps",
  "status": "REVOKED",
  "name_en": "Lidorat 20 mg - 5 mg",
  "name_fr": "Lidorat 20 mg - 5 mg",
  "name_nl": "Lidorat 20 mg - 5 mg",
  "amp_code": "SAM427655-00",
  "strengths": [
    "25.2600",
    "20.0000",
    "5.0000"
  ],
  "pack_count": 10,
  "substances": [
    "Atorvastatin Lysine",
    "Atorvastatin",
    "Amlodipine Besilate",
    "Amlodipine"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Atorvastatin and Amlodipine",
  "authorisation_numbers": [
    "BE427655"
  ]
}
API referenceMCP serverPlans

See everything about atorvastatin and amlodipine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console